On this page

Function is a useful starting point

People with DISH have different burdens. Some live with an incidental imaging finding; others need help with stiffness, pain, daily activities or a particular complication. A useful follow-up conversation begins with what has changed in function, rather than assuming the appearance of the scan describes the whole experience.1

Describe activities that are harder, symptoms that interrupt sleep or eating, and the impact on work or caregiving. A treating team may discuss rehabilitation, occupational adaptations or pain care. The plan should fit the person's clinical findings and goals; it cannot be derived from a universal stretching routine.

Movement and general health

Professional rehabilitation may help maintain useful movement and strength within the limits of the individual spine. The small DISH exercise study found modest physical changes over 24 weeks, without a control group or evidence of reversing ossification. It supports discussion of tailored rehabilitation, not a prescription to force stiff segments or copy the study program.2

Diabetes, blood pressure, lipids and other general health issues deserve their own care. The association of DISH with metabolic conditions does not establish that correcting one factor stops its bone growth. Ask how these conditions and current medicines affect symptom care or an operation. Do not start a supplement or change an existing medicine on the assumption that it cures DISH.3

Progression and life expectancy

Imaging can change over time, but the relationship between additional bone and a person's future symptoms is uncertain. A study endpoint such as a more complete bridge on CT is not the same as disability. Prognosis discussions should concern the actual complication, general health, function and planned treatment.3

Disability can mean difficulty performing a task, a clinical functional assessment or eligibility under a legal system. These are different uses of the word. A diagnosis alone does not determine benefit eligibility. Documentation of the person's limitations and the relevant local rules is needed.

After an osteophyte operation

Follow-up should measure the problem the operation was intended to address. For cervical dysphagia, swallowing symptoms and function may matter alongside images. For a proposed thoracic procedure, pain, function and any claimed organ outcome need their own defined measures and evidence. An early improvement is not automatically permanent relief.

Radiographic regrowth means new bone is visible. Symptomatic recurrence means the original clinical problem returns. Reoperation means another procedure is performed. Miyamoto's seven cervical patients illustrate the distinction: all had visible regrowth, five were symptom-free at final follow-up, two developed later dysphagia, and one had another operation. The mean follow-up was nine years, range six–thirteen. These observations do not predict a thoracic recurrence schedule.4

Chung's shorter cervical follow-up found symptom relapse in three of the 17 cases with later complete measurements, without further surgery during that period. The paper's 29.5-month summary is labeled inconsistently as mean or median. Different follow-up duration and definitions make a direct rate comparison misleading.5

Agree on when to return

Ask which changes should prompt a new appointment, what follow-up is intended to detect and whether repeat imaging would change care. Significant new spinal pain after injury or new neurological symptoms should prompt professional assessment rather than wait for routine follow-up.6

Keep a concise list of symptoms, previous studies and questions for the team. Recovery and surveillance plans belong to that discussion. The goal is to understand and manage the person's problems while acknowledging what the evidence cannot yet predict.

References

  1. Cleveland Clinic. Diffuse Idiopathic Skeletal Hyperostosis. Updated 28 April 2024. Source ↩
  2. Al-Herz A et al. Clinical Rheumatology. 2008;27:207–210. doi:10.1007/s10067-007-0693-z. PubMed ↩
  3. Mader R et al. RMD Open. 2017;3:e000472. doi:10.1136/rmdopen-2017-000472. Source ↩
  4. Miyamoto K et al. European Spine Journal. 2009;18:1652–1658. doi:10.1007/s00586-009-1133-3. PubMed ↩
  5. Chung YS et al. Yonsei Medical Journal. 2020;61:341–348. doi:10.3349/ymj.2020.61.4.341. Source ↩
  6. Reinhold M et al. Global Spine Journal. 2018;8(2 Suppl):56S–68S. doi:10.1177/2192568217736268. Source ↩